{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:35:04Z","timestamp":1760488504803,"version":"build-2065373602"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04483-8","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T15:47:38Z","timestamp":1760456858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging roles of non-coding RNAs in idiopathic nephrotic syndrome: a narrative review"],"prefix":"10.1186","volume":"26","author":[{"given":"Ziyu","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengmin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"4483_CR1","doi-asserted-by":"crossref","unstructured":"Zabala Ramirez MJ, Stein EJ, Jain K. Nephrotic syndrome for the internist. Med Clin N Am. 2023;107(4):727\u201337.","DOI":"10.1016\/j.mcna.2023.03.006"},{"key":"4483_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.12688\/f1000research.10165.1","volume":"6","author":"A Bierzynska","year":"2017","unstructured":"Bierzynska A, Saleem M. Recent advances in understanding and treating nephrotic syndrome. F1000Research. 2017;6:121.","journal-title":"F1000Research"},{"issue":"12","key":"4483_CR3","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41581-019-0217-5","volume":"15","author":"MA Saleem","year":"2019","unstructured":"Saleem MA. Molecular stratification of idiopathic nephrotic syndrome. Nat Rev Nephrol. 2019;15(12):750\u201365.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"4483_CR4","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1681\/ASN.2006070710","volume":"18","author":"KW Lai","year":"2007","unstructured":"Lai KW, Wei CL, Tan LK, et al. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol: JASN. 2007;18(5):1476\u201385.","journal-title":"J Am Soc Of Nephrol: JASN"},{"issue":"4","key":"4483_CR5","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/j.1600-6143.2009.02550.x","volume":"9","author":"S Leroy","year":"2009","unstructured":"Leroy S, Guigonis V, Bruckner D, et al. Successful anti-tnfalpha treatment in a child with posttransplant recurrent focal segmental glomerulosclerosis. Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surgeons. 2009;9(4):858\u201361.","journal-title":"Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surgeons"},{"key":"4483_CR6","doi-asserted-by":"crossref","unstructured":"Bitzan M, Babayeva S, Vasudevan A, et al. Tnf\u03b1 pathway blockade ameliorates toxic effects of fsgs plasma on podocyte cytoskeleton and \u03b23 integrin activation. Pediatric nephrology. Vol. 27(12): Berlin, Germany; 2012. p. 2217\u201326.","DOI":"10.1007\/s00467-012-2163-3"},{"issue":"11","key":"4483_CR7","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.2215\/CJN.03800609","volume":"5","author":"ET McCarthy","year":"2010","unstructured":"McCarthy ET, Sharma M, Savin VJ. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2010;5(11):2115\u201321.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4483_CR8","doi-asserted-by":"crossref","unstructured":"Bakker WW, van Dael CM, Pierik LJ, et al. Altered activity of plasma hemopexin in patients with minimal change disease in relapse. Pediatric nephrology. Vol. 20(10): Berlin, Germany; 2005. p. 1410\u201315.","DOI":"10.1007\/s00467-005-1936-3"},{"issue":"11","key":"4483_CR9","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1681\/ASN.2007080940","volume":"19","author":"R Lennon","year":"2008","unstructured":"Lennon R, Singh A, Welsh GI, et al. Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes. J Am Soc Nephrol: JASN. 2008;19(11):2140\u201349.","journal-title":"J Am Soc Of Nephrol: JASN"},{"key":"4483_CR10","doi-asserted-by":"crossref","unstructured":"Maas RJ, Deegens JK, Wetzels JF. Serum supar in patients with fsgs: trash or treasure? Pediatric nephrology. Vol. 28(7): Berlin, Germany; 2013. p. 1041\u201348.","DOI":"10.1007\/s00467-013-2452-5"},{"issue":"2","key":"4483_CR11","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1046\/j.1523-1755.2000.00870.x","volume":"57","author":"C Frank","year":"2000","unstructured":"Frank C, Herrmann M, Fernandez S, et al. Dominant t cells in idiopathic nephrotic syndrome of childhood. Kidney Int. 2000;57(2):510\u201317.","journal-title":"Kidney Int"},{"key":"4483_CR12","doi-asserted-by":"crossref","unstructured":"Guigonis V, Dallocchio A, Baudouin V, et al. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatric nephrology. Vol. 23(8): Berlin, Germany; 2008. p. 1269\u201379.","DOI":"10.1007\/s00467-008-0814-1"},{"key":"4483_CR13","doi-asserted-by":"crossref","unstructured":"Araya CE, Dharnidharka VR. The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review. J transplant. 2011, 2011;374213.","DOI":"10.1155\/2011\/374213"},{"issue":"14","key":"4483_CR14","first-page":"1366","volume":"391","author":"M Bruschi","year":"2024","unstructured":"Bruschi M, Angeletti A, Ghiggeri GM. Autoantibodies targeting nephrin in podocytopathies. NEJM evid. 2024;391(14):1366.","journal-title":"NEJM evid"},{"issue":"4","key":"4483_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.kint.2024.07.022","volume":"106","author":"I Batal","year":"2024","unstructured":"Batal I, Watts AJB, Gibier JB, et al. Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft. Kidney Int. 2024;106(4):749\u201352.","journal-title":"Kidney Int"},{"issue":"3","key":"4483_CR16","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.kint.2023.11.022","volume":"105","author":"Y Shirai","year":"2024","unstructured":"Shirai Y, Miura K, Ishizuka K, et al. A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence. Kidney Int. 2024;105(3):608\u201317.","journal-title":"Kidney Int"},{"issue":"6","key":"4483_CR17","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.kint.2024.09.006","volume":"106","author":"V Raglianti","year":"2024","unstructured":"Raglianti V, Angelotti ML, Cirillo L, et al. Anti-slit diaphragm antibodies on kidney biopsy identify pediatric patients with steroid-resistant nephrotic syndrome responsive to second-line immunosuppressants. Kidney Int. 2024;106(6):1124\u201334.","journal-title":"Kidney Int"},{"issue":"6","key":"4483_CR18","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.kint.2023.06.032","volume":"104","author":"S Sethi","year":"2023","unstructured":"Sethi S, Beck LH Jr., Glassock RJ, et al. Mayo clinic consensus report on membranous nephropathy: proposal for a novel classification. Kidney Int. 2023;104(6):1092\u2013102.","journal-title":"Kidney Int"},{"key":"4483_CR19","doi-asserted-by":"crossref","unstructured":"Hombach S, Kretz M. Non-coding rnas: classification, biology and functioning. Advances in experimental medicine and biology. 2016;937:3\u201317.","DOI":"10.1007\/978-3-319-42059-2_1"},{"issue":"3","key":"4483_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth K, Bayraktar R, Ferracin M, et al. Non-coding rnas in disease: from mechanisms to therapeutics. Nat Rev Genet. 2024;25(3):211\u201332.","journal-title":"Nat Rev Genet"},{"issue":"11","key":"4483_CR21","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.3390\/ijms22116077","volume":"22","author":"JA Moreno","year":"2021","unstructured":"Moreno JA, Hamza E, Guerrero-Hue M, et al. Non-coding rnas in kidney diseases: the long and short of them. Int J Mol Sci. 2021;22(11):6077.","journal-title":"Int J Mol Sci"},{"key":"4483_CR22","doi-asserted-by":"publisher","first-page":"583528","DOI":"10.3389\/fphar.2020.583528","volume":"11","author":"YY Gu","year":"2020","unstructured":"Gu YY, Lu FH, Huang XR, et al. Non-coding rnas as biomarkers and therapeutic targets for diabetic kidney disease. Front Pharmacol. 2020;11:583528.","journal-title":"Front Pharmacol"},{"key":"4483_CR23","doi-asserted-by":"crossref","unstructured":"Zhao C, Hu J, Wang Z, et al. Serum lncrna pandar may act as a novel serum biomarker of diabetic nephropathy in patients with type 2 diabetes. Clin Lab. 2020;66(6).","DOI":"10.7754\/Clin.Lab.2019.191032"},{"issue":"5","key":"4483_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2174\/1566524019666191019103918","volume":"20","author":"SI Tayel","year":"2020","unstructured":"Tayel SI, Saleh AA, El-Hefnawy SM, et al. Simultaneous assessment of micrornas 126 and 192 in diabetic nephropathy patients and the relation of these micrornas with urinary albumin. Curr Mol Med. 2020;20(5):361\u201371.","journal-title":"Curr Mol Med"},{"key":"4483_CR25","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.12659\/MSM.909510","volume":"24","author":"L Wang","year":"2018","unstructured":"Wang L, Su N, Zhang Y, et al. Clinical significance of serum lncrna cancer susceptibility candidate 2 (casc2) for chronic renal failure in patients with type 2 diabetes. Med Sci Monit: Int Med J Exp Clin Res. 2018;24:6079\u201384.","journal-title":"Med Sci Monit: Int Med J Exp And Clin Res"},{"key":"4483_CR26","doi-asserted-by":"crossref","unstructured":"Zhang X, Tian H, Lu C, et al. Long non-coding rna growth arrest specific 5 regulates the podocyte function in nephrotic syndrome development via microrna-144-5p\/phosphatase and tensin homolog. Nephrology (Carlton, Vic). 2025;30(4):e70024.","DOI":"10.1111\/nep.70024"},{"issue":"2","key":"4483_CR27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/biomedicines11020514","volume":"11","author":"S Hayward","year":"2023","unstructured":"Hayward S, Parmesar K, Welsh GI, et al. Epigenetic mechanisms and nephrotic syndrome: a systematic review. Biomedicines. 2023;11(2):514.","journal-title":"Biomedicines"},{"key":"4483_CR28","doi-asserted-by":"crossref","unstructured":"Charmine P, Venkatesan V, Geminiganesan S, et al. Deciphering the urinary micrornas landscape in nephrotic syndrome: implications as prognostic marker-a non-invasive study. Int Urology Nephrol. 2025.","DOI":"10.1007\/s11255-025-04546-7"},{"issue":"4","key":"4483_CR29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10157-024-02595-3","volume":"29","author":"A Sinha","year":"2025","unstructured":"Sinha A, Sra M, Ahmed A, et al. Micrornas in idiopathic childhood nephrotic syndrome. Clin Exp Nephrol. 2025;29(4):477\u201384.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"4483_CR30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12967-022-03430-7","volume":"20","author":"IO Sun","year":"2022","unstructured":"Sun IO, Bae YU, Lee H, et al. Circulating mirnas in extracellular vesicles related to treatment response in patients with idiopathic membranous nephropathy. J Transl Med. 2022;20(1):224.","journal-title":"J Transl Med"},{"issue":"7209","key":"4483_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature07228","volume":"455","author":"M Selbach","year":"2008","unstructured":"Selbach M, Schwanh\u00e4usser B, Thierfelder N, et al. Widespread changes in protein synthesis induced by micrornas. Nature. 2008;455(7209):58\u201363.","journal-title":"Nature"},{"issue":"7209","key":"4483_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature07242","volume":"455","author":"D Baek","year":"2008","unstructured":"Baek D, Vill\u00e9n J, Shin C, et al. The impact of micrornas on protein output. Nature. 2008;455(7209):64\u201371.","journal-title":"Nature"},{"issue":"7014","key":"4483_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature03049","volume":"432","author":"AM Denli","year":"2004","unstructured":"Denli AM, Tops BB, Plasterk RH, et al. Processing of primary micrornas by the microprocessor complex. Nature. 2004;432(7014):231\u201335.","journal-title":"Nature"},{"key":"4483_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, et al. Overview of microrna biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9:402.","journal-title":"Front Endocrinol"},{"issue":"1","key":"4483_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cell.2004.06.017","volume":"118","author":"H Zhang","year":"2004","unstructured":"Zhang H, Kolb FA, Jaskiewicz L, et al. Single processing center models for human dicer and bacterial rnase iii. Cell. 2004;118(1):57\u201368.","journal-title":"Cell"},{"issue":"2","key":"4483_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrg2936","volume":"12","author":"E Huntzinger","year":"2011","unstructured":"Huntzinger E, Izaurralde E. Gene silencing by micrornas: contributions of translational repression and mrna decay. Nat Rev Genet. 2011;12(2):99\u2013110.","journal-title":"Nat Rev Genet"},{"key":"4483_CR37","doi-asserted-by":"crossref","unstructured":"Forman JJ, Legesse-Miller A, Coller HA. A search for conserved sequences in coding regions reveals that the let-7 microrna targets dicer within its coding sequence. Proceedings of the National Academy of Sciences of the United States of America. 2008): 14879\u201384, 105(39).","DOI":"10.1073\/pnas.0803230105"},{"issue":"5","key":"4483_CR38","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.3892\/ol.2018.8296","volume":"15","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhou W, Liu Y, et al. Oncogenic role of microrna-532-5p in human colorectal cancer via targeting of the 5\u2018utr of runx3. Oncol Lett. 2018;15(5):7215\u201320.","journal-title":"Oncol Lett"},{"issue":"2","key":"4483_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.molcel.2016.09.004","volume":"64","author":"JP Broughton","year":"2016","unstructured":"Broughton JP, Lovci MT, Huang JL, et al. Pairing beyond the seed supports microrna targeting specificity. Mol Cell. 2016;64(2):320\u201333.","journal-title":"Mol Cell"},{"issue":"18","key":"4483_CR40","doi-asserted-by":"publisher","first-page":"6738","DOI":"10.3390\/ijms21186738","volume":"21","author":"YL Wu","year":"2020","unstructured":"Wu YL, Li HF, Chen HH, et al. Micrornas as biomarkers and therapeutic targets in inflammation- and ischemia-reperfusion-related acute renal injury. Int J Mol Sci. 2020;21(18):6738.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4483_CR41","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41581-022-00608-6","volume":"18","author":"N Mahtal","year":"2022","unstructured":"Mahtal N, Lenoir O, Tinel C, et al. Micrornas in kidney injury and disease. Nat Rev Nephrol. 2022;18(10):643\u201362.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"4483_CR42","doi-asserted-by":"publisher","first-page":"e158277","DOI":"10.1172\/jci.insight.158277","volume":"7","author":"DM Cerqueira","year":"2022","unstructured":"Cerqueira DM, Tayeb M, Ho J. Micrornas in kidney development and disease. JCI Insight. 2022;7(9):e158277.","journal-title":"JCI Insight"},{"key":"4483_CR43","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ebiom.2018.11.018","volume":"39","author":"T Chen","year":"2019","unstructured":"Chen T, Wang C, Yu H, et al. Increased urinary exosomal micrornas in children with idiopathic nephrotic syndrome. EBioMedicine. 2019;39:552\u201361.","journal-title":"EBioMedicine"},{"issue":"4","key":"4483_CR44","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1373\/clinchem.2012.195297","volume":"59","author":"Y Luo","year":"2013","unstructured":"Luo Y, Wang C, Chen X, et al. Increased serum and urinary micrornas in children with idiopathic nephrotic syndrome. Clin Chem. 2013;59(4):658\u201366.","journal-title":"Clin Chem"},{"issue":"9","key":"4483_CR45","first-page":"958","volume":"22","author":"YR Zhang","year":"2020","unstructured":"Zhang YR, Wu YF, Wang H, et al. [Role of microrna-17-5p in the pathogenesis of pediatric nephrotic syndrome and related mechanisms]. Zhongguo dang dai er ke za zhi =. Chin J Contemp Pediatrics. 2020;22(9):958\u201363.","journal-title":"Chin J Contemp Pediatrics"},{"issue":"12","key":"4483_CR46","first-page":"1917","volume":"61","author":"H Wang","year":"2015","unstructured":"Wang H, Hu Z, Chen L. Decreased serum mir-503 level in children with nephrotic syndrome. Clin Lab. 2015;61(12):1917\u201326.","journal-title":"Clin Lab"},{"issue":"7","key":"4483_CR47","doi-asserted-by":"publisher","first-page":"6591","DOI":"10.1007\/s11033-022-07500-3","volume":"49","author":"MC Dandapani","year":"2022","unstructured":"Dandapani MC, Venkatesan V, Charmine P, et al. Differential urinary microrna expression analysis of mir-1, mir-215, mir-335, let-7a in childhood nephrotic syndrome. Mol Biol Rep. 2022;49(7):6591\u2013600.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"4483_CR48","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.yexmp.2015.10.003","volume":"99","author":"M Lu","year":"2015","unstructured":"Lu M, Wang C, Yuan Y, et al. Differentially expressed micrornas in kidney biopsies from various subtypes of nephrotic children. Exp Mol Pathol. 2015;99(3):590\u201395.","journal-title":"Exp And Mol Pathol"},{"key":"4483_CR49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cca.2012.12.011","volume":"418","author":"G Wang","year":"2013","unstructured":"Wang G, Kwan BC, Lai FM, et al. Urinary sediment mirna levels in adult nephrotic syndrome. Clinica (rome) Acta; Int J Clin Chem. 2013;418:5\u201311.","journal-title":"Clinica (rome) Acta; Int J Clin Chem"},{"key":"4483_CR50","doi-asserted-by":"crossref","unstructured":"Zapata-Benavides P, Arellano-Rodr\u00edguez M, Bollain YGJJ, et al. Cytoplasmic localization of wt1 and decrease of mirna-16-1 in nephrotic syndrome. Biomed Res Int. 2017, 2017;9531074.","DOI":"10.1155\/2017\/9531074"},{"issue":"6","key":"4483_CR51","first-page":"7282","volume":"8","author":"J Teng","year":"2015","unstructured":"Teng J, Sun F, Yu PF, et al. Differential microrna expression in the serum of patients with nephrotic syndrome and clinical correlation analysis. Int J Clin Exp Pathol. 2015;8(6):7282\u201386.","journal-title":"Int J Clin Exp Pathol"},{"key":"4483_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.molimm.2021.11.004","volume":"141","author":"NR Bayomy","year":"2022","unstructured":"Bayomy NR, Abo Alfottoh WM, Ali Eldeep SA, et al. Mir-142-5p as an indicator of autoimmune processes in childhood idiopathic nephrotic syndrome and as a part of micrornas expression panels for its diagnosis and prediction of response to steroid treatment. Mol Immunol. 2022;141:21\u201332.","journal-title":"Mol Immunol"},{"key":"4483_CR53","doi-asserted-by":"publisher","first-page":"651544","DOI":"10.3389\/fped.2021.651544","volume":"9","author":"FF Ni","year":"2021","unstructured":"Ni FF, Liu GL, Jia SL, et al. Function of mir-24 and mir-27 in pediatric patients with idiopathic nephrotic syndrome. Front pediatr. 2021;9:651544.","journal-title":"Front pediatr"},{"issue":"2","key":"4483_CR54","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000486967","volume":"47","author":"K Zhang","year":"2018","unstructured":"Zhang K, Sun W, Zhang L, et al. Mir-499 ameliorates podocyte injury by targeting calcineurin in minimal change disease. Am J Nephrol. 2018;47(2):94\u2013102.","journal-title":"Am J Nephrol"},{"issue":"11","key":"4483_CR55","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s41419-018-1178-5","volume":"9","author":"Z Zheng","year":"2018","unstructured":"Zheng Z, Hu H, Tong Y, et al. Mir-27b regulates podocyte survival through targeting adenosine receptor 2b in podocytes from non-human primate. Cell Death Dis. 2018;9(11):1133.","journal-title":"Cell Death Dis"},{"issue":"4","key":"4483_CR56","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/eci.12420","volume":"45","author":"A Ramezani","year":"2015","unstructured":"Ramezani A, Devaney JM, Cohen S, et al. Circulating and urinary microrna profile in focal segmental glomerulosclerosis: A pilot study. Eur J Clin Invest. 2015;45(4):394\u2013404.","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"4483_CR57","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3892\/ijmm.2017.3152","volume":"40","author":"X Yang","year":"2017","unstructured":"Yang X, Wu D, Du H, et al. Microrna-135a is involved in podocyte injury in a transient receptor potential channel 1-dependent manner. Int J Mol Med. 2017;40(5):1511\u201319.","journal-title":"Int J Mol Med"},{"issue":"4","key":"4483_CR58","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nm.3142","volume":"19","author":"CA Gebeshuber","year":"2013","unstructured":"Gebeshuber CA, Kornauth C, Dong L, et al. Focal segmental glomerulosclerosis is induced by microrna-193a and its downregulation of wt1. Nat Med. 2013;19(4):481\u201387.","journal-title":"Nat Med"},{"issue":"5","key":"4483_CR59","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41419-018-0569-y","volume":"9","author":"B Xiao","year":"2018","unstructured":"Xiao B, Wang LN, Li W, et al. Plasma microrna panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis. Cell Death Dis. 2018;9(5):533.","journal-title":"Cell Death Dis"},{"key":"4483_CR60","doi-asserted-by":"publisher","first-page":"119671","DOI":"10.1016\/j.lfs.2021.119671","volume":"280","author":"D Yildirim","year":"2021","unstructured":"Yildirim D, Bender O, Karagoz ZF, et al. Role of autophagy and evaluation the effects of micrornas 214, 132, 34c and prorenin receptor in a rat model of focal segmental glomerulosclerosis. Life Sci. 2021;280:119671.","journal-title":"Life Sci"},{"issue":"2","key":"4483_CR61","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000525233","volume":"147","author":"G Liu","year":"2023","unstructured":"Liu G, He L, Yang X, et al. Microrna-155-5p aggravates adriamycin-induced focal segmental glomerulosclerosis through targeting nrf2. Nephron. 2023;147(2):108\u201319.","journal-title":"Nephron"},{"issue":"2","key":"4483_CR62","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1053\/j.ajkd.2014.07.013","volume":"65","author":"C Zhang","year":"2015","unstructured":"Zhang C, Zhang W, Chen HM, et al. Plasma microrna-186 and proteinuria in focal segmental glomerulosclerosis. Am J Kidney Dis: the Off J Natl Kidney foundation. 2015;65(2):223\u201332.","journal-title":"Am J Kidney Dis: The Off J Natl Kidney foundation"},{"key":"4483_CR63","doi-asserted-by":"publisher","first-page":"727370","DOI":"10.3389\/fcell.2021.727370","volume":"9","author":"L Wang","year":"2021","unstructured":"Wang L, Wang J, Wang Z, et al. Higher urine exosomal mir-193a is associated with a higher probability of primary focal segmental glomerulosclerosis and an increased risk of poor prognosis among children with nephrotic syndrome. Front. Cell Dev. Biol. 2021;9:727370.","journal-title":"Front. Cell Dev. Biol"},{"key":"4483_CR64","doi-asserted-by":"crossref","unstructured":"Cai X, Xia Z, Zhang C, et al. Serum micrornas levels in primary focal segmental glomerulosclerosis. Pediatric nephrology. Vol. 28(9): Berlin, Germany; 2013. p. 1797\u2013801.","DOI":"10.1007\/s00467-013-2434-7"},{"key":"4483_CR65","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/IJNRD.S258624","volume":"13","author":"SM Hejazian","year":"2020","unstructured":"Hejazian SM, Ardalan M, Shoja MM, et al. Expression levels of mir-30c and mir-186 in adult patients with membranous glomerulonephritis and focal segmental glomerulosclerosis. Int J Nephrol Renovasc Dis. 2020;13:193\u2013201.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"1","key":"4483_CR66","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1681\/ASN.2012111101","volume":"25","author":"J Wu","year":"2014","unstructured":"Wu J, Zheng C, Fan Y, et al. Downregulation of microrna-30 facilitates podocyte injury and is prevented by glucocorticoids. J Am Soc Nephrol: JASN. 2014;25(1):92\u2013104.","journal-title":"J Am Soc Of Nephrol: JASN"},{"issue":"12","key":"4483_CR67","doi-asserted-by":"publisher","first-page":"e51140","DOI":"10.1371\/journal.pone.0051140","volume":"7","author":"N Wang","year":"2012","unstructured":"Wang N, Zhou Y, Jiang L, et al. Urinary microrna-10a and microrna-30d serve as novel, sensitive and specific biomarkers for kidney injury. PLoS One. 2012;7(12):e51140.","journal-title":"PLoS One"},{"issue":"9","key":"4483_CR68","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2215\/CJN.11561113","volume":"9","author":"W Zhang","year":"2014","unstructured":"Zhang W, Zhang C, Chen H, et al. Evaluation of micrornas mir-196a, mir-30a-5p, and mir-490 as biomarkers of disease activity among patients with fsgs. Clin J Am Soc Nephrol. 2014;9(9):1545\u201352.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4483_CR69","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbrc.2021.04.003","volume":"557","author":"X Qiu","year":"2021","unstructured":"Qiu X, Huo J, Xia S, et al. Dysfunction of the klotho-mir-30s\/trpc6 axis confers podocyte injury. Biochem Bioph Res Co. 2021;557:90\u201396.","journal-title":"Biochem Bioph Res Co"},{"issue":"6","key":"4483_CR70","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41419-019-1625-y","volume":"10","author":"Y Lang","year":"2019","unstructured":"Lang Y, Zhao Y, Zheng C, et al. Mir-30 family prevents upar-itgb3 signaling activation through calcineurin-nfatc pathway to protect podocytes. Cell Death Dis. 2019;10(6):401.","journal-title":"Cell Death Dis"},{"key":"4483_CR71","doi-asserted-by":"crossref","unstructured":"Zhao Y, Wu J, Zhang M, et al. Angiotensin ii induces calcium\/calcineurin signaling and podocyte injury by downregulating microrna-30 family members. In: Journal of molecular medicine. Vol. 95(8): Berlin, Germany; 2017. p. 887\u201398.","DOI":"10.1007\/s00109-017-1547-z"},{"issue":"11","key":"4483_CR72","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1172\/JCI81061","volume":"125","author":"J Wu","year":"2015","unstructured":"Wu J, Zheng C, Wang X, et al. Microrna-30 family members regulate calcium\/calcineurin signaling in podocytes. J. Clin. Invest. 2015;125(11):4091\u2013106.","journal-title":"J. Clin. Invest"},{"key":"4483_CR73","doi-asserted-by":"crossref","unstructured":"Liu L, Lin W, Zhang Q, et al. Tgf-\u03b2 induces mir-30d down-regulation and podocyte injury through smad2\/3 and hdac3-associated transcriptional repression. In: Journal of molecular medicine. Vol. 94(3): Berlin, Germany; 2016. p. 291\u2013300.","DOI":"10.1007\/s00109-015-1340-9"},{"issue":"9","key":"4483_CR74","doi-asserted-by":"publisher","first-page":"e75572","DOI":"10.1371\/journal.pone.0075572","volume":"8","author":"S Shi","year":"2013","unstructured":"Shi S, Yu L, Zhang T, et al. Smad2-dependent downregulation of mir-30 is required for tgf-\u03b2-induced apoptosis in podocytes. PLoS One. 2013;8(9):e75572.","journal-title":"PLoS One"},{"key":"4483_CR75","doi-asserted-by":"crossref","unstructured":"Xu Z, Chen L, Xiang H, et al. Advances in pathogenesis of idiopathic membranous nephropathy. Kidney diseases. Vol. 6(5): Basel, Switzerland; 2020. p. 330\u201345.","DOI":"10.1159\/000507704"},{"key":"4483_CR76","doi-asserted-by":"publisher","first-page":"9364","DOI":"10.12659\/MSM.917732","volume":"25","author":"N Guo","year":"2019","unstructured":"Guo N, Cao Y, Dai H, et al. Anti-phospholipase a2 receptor (anti-pla2r) antibody in diagnosis and treatment of idiopathic membranous nephropathy: A single-center observational study in China. Med Sci Monit: Int Med J Exp Clin Res. 2019;25:9364\u201368.","journal-title":"Med Sci Monit: Int Med J Exp And Clin Res"},{"issue":"1","key":"4483_CR77","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/ijms22010088","volume":"22","author":"K Tsuji","year":"2020","unstructured":"Tsuji K, Kitamura S, Wada J. Micrornas as biomarkers for nephrotic syndrome. Int J Mol Sci. 2020;22(1):88.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4483_CR78","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3892\/ijmm.2013.1554","volume":"33","author":"W Chen","year":"2014","unstructured":"Chen W, Lin X, Huang J, et al. Integrated profiling of microrna expression in membranous nephropathy using high-throughput sequencing technology. Int J Mol Med. 2014;33(1):25\u201334.","journal-title":"Int J Mol Med"},{"key":"4483_CR79","doi-asserted-by":"crossref","unstructured":"Li J, Liu B, Xue H, et al. Mir-217 is a useful diagnostic biomarker and regulates human podocyte cells apoptosis via targeting tnfsf11 in membranous nephropathy. Biomed Res Int. 2017, 2017;2168767.","DOI":"10.1155\/2017\/2168767"},{"issue":"5","key":"4483_CR80","doi-asserted-by":"publisher","first-page":"13956","DOI":"10.1080\/21655979.2022.2083822","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen J, Hu Q, Luo Y, et al. Salvianolic acid b attenuates membranous nephropathy by activating renal autophagy via microrna-145-5p\/phosphatidylinositol 3-kinase\/akt pathway. Bioengineered. 2022;13(5):13956\u201369.","journal-title":"Bioengineered"},{"key":"4483_CR81","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.biopha.2015.07.021","volume":"75","author":"WG Sha","year":"2015","unstructured":"Sha WG, Shen L, Zhou L, et al. Down-regulation of mir-186 contributes to podocytes apoptosis in membranous nephropathy. Biomed & Pharmacother. 2015;75:179\u201384.","journal-title":"Biomed & Pharmacother"},{"issue":"4","key":"4483_CR82","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1620\/tjem.2022.J002","volume":"256","author":"S Guo","year":"2022","unstructured":"Guo S, Hao H, Li S, et al. Differential expression of urinary exosomal mirna in idiopathic membranous nephropathy and evaluation of its diagnostic value. Tohoku J Exp Med. 2022;256(4):327\u201336.","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"4483_CR83","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1080\/0886022X.2019.1642210","volume":"41","author":"W Zhang","year":"2019","unstructured":"Zhang W, Ren Y, Li J. Application of mir-193a\/wt1\/podxl axis to estimate risk and prognosis of idiopathic membranous nephropathy. Ren Fail. 2019;41(1):704\u201317.","journal-title":"Ren Fail"},{"key":"4483_CR84","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.12659\/MSM.913057","volume":"25","author":"G Zhou","year":"2019","unstructured":"Zhou G, Zhang X, Wang W, et al. Both peripheral blood and urinary mir-195-5p, mir-192-3p, mir-328-5p and their target genes ppm1a, rab1a and brsk1 may be potential biomarkers for membranous nephropathy. Med Sci Monit: Int Med J Exp Clin Res. 2019;25:1903\u201316.","journal-title":"Med Sci Monit: Int Med J Exp And Clin Res"},{"issue":"4","key":"4483_CR85","doi-asserted-by":"publisher","first-page":"e23737","DOI":"10.1002\/jcla.23737","volume":"35","author":"L Wu","year":"2021","unstructured":"Wu L, Zhang X, Luo L, et al. Altered expression of serum mir-106a, mir-19b, mir-17, and pten in patients with idiopathic membranous nephropathy. J Clin Lab Anal. 2021;35(4):e23737.","journal-title":"J Clin Lab Anal"},{"issue":"8","key":"4483_CR86","doi-asserted-by":"publisher","first-page":"12625","DOI":"10.1002\/jcp.27851","volume":"234","author":"C Barbagallo","year":"2019","unstructured":"Barbagallo C, Passanisi R, Mirabella F, et al. Upregulated micrornas in membranous glomerulonephropathy are associated with significant downregulation of il6 and myc mrnas. J Cell Physiol. 2019;234(8):12625\u201336.","journal-title":"J Cell Physiol"},{"issue":"3","key":"4483_CR87","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding rnas. Cell. 2018;172(3):393\u2013407.","journal-title":"Cell"},{"issue":"3","key":"4483_CR88","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ncrna4030017","volume":"4","author":"JS Mattick","year":"2018","unstructured":"Mattick JS. The state of long non-coding rna biology. Non-Coding RNA. 2018;4(3):17.","journal-title":"Non-Coding RNA"},{"key":"4483_CR89","doi-asserted-by":"publisher","first-page":"e922090","DOI":"10.12659\/MSM.922090","volume":"26","author":"J Xu","year":"2020","unstructured":"Xu J, Ge T, Zhou H, et al. Absence of long noncoding rna h19 promotes childhood nephrotic syndrome through inhibiting adck4 signal. Med Sci Monit: Int Med J Exp And Clin Res. 2020;26:e922090.","journal-title":"Med Sci Monit: Int Med J Exp And Clin Res"},{"issue":"1","key":"4483_CR90","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3892\/br.2020.1393","volume":"14","author":"FJ Salazar-Torres","year":"2021","unstructured":"Salazar-Torres FJ, Medina-Perez M, Melo Z, et al. Urinary expression of long non-coding rna tug1 in non-diabetic patients with glomerulonephritides. Biomed Rep. 2021;14(1):17.","journal-title":"Biomed Rep"},{"issue":"52","key":"4483_CR91","doi-asserted-by":"publisher","first-page":"20227","DOI":"10.1074\/jbc.RA118.005579","volume":"293","author":"S Hu","year":"2018","unstructured":"Hu S, Han R, Shi J, et al. The long noncoding rna loc105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis. J Biol Chem. 2018;293(52):20227\u201339.","journal-title":"J Biol Chem"},{"issue":"1","key":"4483_CR92","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41598-018-36902-2","volume":"9","author":"R Han","year":"2019","unstructured":"Han R, Hu S, Qin W, et al. Upregulated long noncoding rna loc105375913 induces tubulointerstitial fibrosis in focal segmental glomerulosclerosis. Sci Rep. 2019;9(1):716.","journal-title":"Sci Rep"},{"issue":"2","key":"4483_CR93","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1113\/EP087190","volume":"104","author":"LW Jin","year":"2019","unstructured":"Jin LW, Pan M, Ye HY, et al. Down-regulation of the long non-coding rna xist ameliorates podocyte apoptosis in membranous nephropathy via the mir-217-tlr4 pathway. Exp Physiol. 2019;104(2):220\u201330.","journal-title":"Exp Physiol"},{"issue":"3","key":"4483_CR94","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbrc.2014.08.077","volume":"452","author":"YS Huang","year":"2014","unstructured":"Huang YS, Hsieh HY, Shih HM, et al. Urinary xist is a potential biomarker for membranous nephropathy. Biochem Bioph Res Co. 2014;452(3):415\u201321.","journal-title":"Biochem Bioph Res Co"},{"issue":"8","key":"4483_CR95","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/08916934.2021.1972289","volume":"54","author":"P Pi","year":"2021","unstructured":"Pi P, Yin Q, Xiao L, et al. Long non-coding rna neat1 triggers renal tubular epithelial cell apoptosis via activating bh3-only protein in membranous nephropathy. Autoimmunity. 2021;54(8):539\u201346.","journal-title":"Autoimmunity"},{"issue":"3","key":"4483_CR96","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3390\/cells10030692","volume":"10","author":"S Talyan","year":"2021","unstructured":"Talyan S, Filip\u00f3w S, Ignarski M, et al. Calinca-a novel pipeline for the identification of lncrnas in podocyte disease. Cells. 2021;10(3):692.","journal-title":"Cells"},{"issue":"2","key":"4483_CR97","doi-asserted-by":"publisher","first-page":"2284212","DOI":"10.1080\/0886022X.2023.2284212","volume":"45","author":"YX Zhang","year":"2023","unstructured":"Zhang YX, Bai JY, Pu X, et al. An integrated bioinformatics approach to identify key biomarkers in the tubulointerstitium of patients with focal segmental glomerulosclerosis and construction of mrna-mirna-lncrna\/circrna networks. Ren Fail. 2023;45(2):2284212.","journal-title":"Ren Fail"},{"issue":"4","key":"4483_CR98","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s12539-021-00466-z","volume":"13","author":"G Zhou","year":"2021","unstructured":"Zhou G, Jiang N, Zhang W, et al. Biomarker identification in membranous nephropathy using a long non-coding rna-mediated competitive endogenous rna network. Interdiscip Sci. 2021;13(4):615\u201323.","journal-title":"Interdiscip Sci"},{"issue":"7441","key":"4483_CR99","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A, et al. Circular rnas are a large class of animal rnas with regulatory potency. Nature. 2013;495(7441):333\u201338.","journal-title":"Nature"},{"issue":"1","key":"4483_CR100","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"WY Zhou","year":"2020","unstructured":"Zhou WY, Cai ZR, Liu J, et al. Circular rna: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19(1):172.","journal-title":"Mol Cancer"},{"issue":"12","key":"4483_CR101","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1111\/jcmm.15295","volume":"24","author":"J Jin","year":"2020","unstructured":"Jin J, Sun H, Shi C, et al. Circular rna in renal diseases. J Cell Mol Med. 2020;24(12):6523\u201333.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"4483_CR102","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li Z, Huang C, Bao C, et al. Exon-intron circular rnas regulate transcription in the nucleus. Nat Struct & Mol Biol. 2015;22(3):256\u201364.","journal-title":"Nat Struct & Mol Biol"},{"issue":"2","key":"4483_CR103","first-page":"269","volume":"116","author":"TB Lim","year":"2020","unstructured":"Lim TB, Lavenniah A, Foo RS. Circles in the heart and cardiovascular system. Cardiovasc Res. 2020;116(2):269\u201378.","journal-title":"Cardiovasc Res"},{"key":"4483_CR104","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ebiom.2018.07.036","volume":"34","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Yang T, Xiao J. Circular rnas: promising biomarkers for human diseases. EBioMedicine. 2018;34:267\u201374.","journal-title":"EBioMedicine"},{"issue":"8","key":"4483_CR105","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/cns.14220","volume":"29","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wan M, Min X, et al. Circular rna as biomarkers for acute ischemic stroke: A systematic review and meta-analysis. CNS Neurosci Ther. 2023;29(8):2086\u2013100.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"4483_CR106","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12943-020-1135-7","volume":"19","author":"M Lei","year":"2020","unstructured":"Lei M, Zheng G, Ning Q, et al. Translation and functional roles of circular rnas in human cancer. Mol Cancer. 2020;19(1):30.","journal-title":"Mol Cancer"},{"issue":"12","key":"4483_CR107","doi-asserted-by":"publisher","first-page":"e22633","DOI":"10.1096\/fj.202201070R","volume":"36","author":"Y Liao","year":"2022","unstructured":"Liao Y, Peng X, Li X, et al. Circrna_45478 promotes ischemic aki by targeting the mir-190a-5p\/phlpp1 axis. Faseb J. 2022;36(12):e22633.","journal-title":"Faseb J"},{"issue":"3","key":"4483_CR108","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41419-022-04612-3","volume":"13","author":"X Cheng","year":"2022","unstructured":"Cheng X, Ai K, Yi L, et al. The mmu_circrna_37492\/hsa_circ_0012138 function as potential cerna to attenuate obstructive renal fibrosis. Cell Death Dis. 2022;13(3):207.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4483_CR109","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-022-01607-8","volume":"21","author":"Z Xu","year":"2022","unstructured":"Xu Z, Chen S, Liu R, et al. Circular rna circpolr2a promotes clear cell renal cell carcinoma progression by facilitating the ube3c-induced ubiquitination of pebp1 and, thereby, activating the erk signaling pathway. Mol Cancer. 2022;21(1):146.","journal-title":"Mol Cancer"},{"issue":"2","key":"4483_CR110","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2337\/db20-0203","volume":"70","author":"F Peng","year":"2021","unstructured":"Peng F, Gong W, Li S, et al. Circrna_010383 acts as a sponge for mir-135a, and its downregulated expression contributes to renal fibrosis in diabetic nephropathy. Diabetes. 2021;70(2):603\u201315.","journal-title":"Diabetes"},{"issue":"3","key":"4483_CR111","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.bbrc.2020.07.066","volume":"531","author":"X Cui","year":"2020","unstructured":"Cui X, Fu J, Luan J, et al. Circznf609 is involved in the pathogenesis of focal segmental glomerulosclerosis by sponging mir-615-5p. Biochem Bioph Res Co. 2020;531(3):341\u201349.","journal-title":"Biochem Bioph Res Co"},{"issue":"5","key":"4483_CR112","first-page":"4125","volume":"20","author":"X Jin","year":"2019","unstructured":"Jin X, Deng B, Ye K, et al. Comprehensive expression profiles and bioinformatics analysis reveal special circular rna expression and potential predictability in the peripheral blood of humans with idiopathic membranous nephropathy. Mol Med Rep. 2019;20(5):4125\u201339.","journal-title":"Mol Med Rep"},{"issue":"3","key":"4483_CR113","doi-asserted-by":"publisher","first-page":"e13414","DOI":"10.1111\/eci.13414","volume":"51","author":"Z Sun","year":"2021","unstructured":"Sun Z, Xu Q, Ma Y, et al. Circ_0000524\/mir-500a-5p\/cxcl16 axis promotes podocyte apoptosis in membranous nephropathy. Eur J Clin Invest. 2021;51(3):e13414.","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"4483_CR114","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/FJC.0000000000001262","volume":"79","author":"D Qiu","year":"2022","unstructured":"Qiu D, Zhao N, Chen Q, et al. Knockdown of circ_cdyl contributes to inhibit angiotensin ii-induced podocytes apoptosis in membranous nephropathy via the mir-149-5p\/tnfsf11 pathway. J Cardiovasc Pharmacol. 2022;79(6):887\u201395.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"4483_CR115","doi-asserted-by":"publisher","first-page":"738","DOI":"10.5114\/aoms.2019.84690","volume":"15","author":"H Ma","year":"2019","unstructured":"Ma H, Xu Y, Zhang R, et al. Differential expression study of circular rnas in exosomes from serum and urine in patients with idiopathic membranous nephropathy. Arch Med Sci. 2019;15(3):738\u201353.","journal-title":"Arch Med Sci"},{"issue":"1","key":"4483_CR116","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1186\/s12967-022-03784-y","volume":"20","author":"Q Li","year":"2022","unstructured":"Li Q, Xu M, Zhang Z, et al. Urinary exosomal hsa_circ_0001250 as a novel diagnostic biomarker of idiopathic membranous nephropathy. J Transl Med. 2022;20(1):607.","journal-title":"J Transl Med"},{"issue":"7644","key":"4483_CR117","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/543183a","volume":"543","author":"K Adelman","year":"2017","unstructured":"Adelman K, Egan E. Non-coding rna: More uses for genomic junk. Nature. 2017;543(7644):183\u201385.","journal-title":"Nature"},{"issue":"3","key":"4483_CR118","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2215\/CJN.05960616","volume":"12","author":"AZ Rosenberg","year":"2017","unstructured":"Rosenberg AZ, Kopp JB. Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2017;12(3):502\u201317.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4483_CR119","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","volume":"7","author":"P Ronco","year":"2021","unstructured":"Ronco P, Beck L, Debiec H, et al. Membranous nephropathy. Nat Rev Dis Primers. 2021;7(1):69.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"4483_CR120","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","volume":"43","author":"VD D\u2019Agati","year":"2004","unstructured":"D\u2019Agati VD, Fogo AB, Bruijn JA, et al. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis: the Off J Natl Kidney foundation. 2004;43(2):368\u201382.","journal-title":"Am J Kidney Dis: The Off J Natl Kidney foundation"},{"issue":"2","key":"4483_CR121","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nrneph.2014.216","volume":"11","author":"AB Fogo","year":"2015","unstructured":"Fogo AB. Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol. 2015;11(2):76\u201387.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"4483_CR122","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.bbrc.2019.11.096","volume":"522","author":"H Qi","year":"2020","unstructured":"Qi H, Fu J, Luan J, et al. Mir-150 inhibitor ameliorates adriamycin-induced focal segmental glomerulosclerosis. Biochem Bioph Res Co. 2020;522(3):618\u201325.","journal-title":"Biochem Bioph Res Co"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04483-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04483-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04483-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T16:06:13Z","timestamp":1760457973000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04483-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4483"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04483-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"565"}}